Answers are grounded in this paper and cite their sources.
Case report reveals diagnostic and treatment challenges in mycetoma of the foot, highlighting implications for care.
Mycetoma or Madura foot is a rare and chronic, progressively destructive granulomatous infection of the skin and subcutaneous tissues, commonly caused by either fungi (eumycetoma) or filamentous bacteria (actinomycetoma). Differentiating between the two is crucial for effective treatment, as management strategies differ significantly. This case report emphasizes the diagnostic dilemma and therapeutic challenges in mycetoma of the foot. Here, we report a 47-year-old male who presented with swellings over the dorsum of the right foot with no discharge for 3 years. He was diagnosed with a case of eumycetoma foot, for which the patient was on antifungal therapy with itraconazole for 3 years with no effect. History of discharging sinus over swelling 3 years back. He underwent debridement for the same 3 years ago, and since then, there has been no discharging sinus, but swelling has recurred, progressively increasing even on medication since then. On examination, swelling of 5 cm × 4 cm over the dorsum of the foot, firm, nodular, irregular margins, with pigmentation of the overlying skin. Complete surgical excision of the multinodular swelling was done, followed by postoperative injection of amikacin with oral cotrimoxazole for 6 months. The key takeaway message is that accurate etiological diagnosis is important in mycetoma. Misdiagnosis can lead to ineffective treatment and prolonged morbidity. Histopathological and cytological evaluation remain essential tools in distinguishing actinomycetoma from eumycetoma, guiding appropriate therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Shinde et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: